Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

KERNX Health vs Primary Clinic (Direct GLP)

KERNX Health
Graded #282

Lower grade

vs+6.800000000000004
Primary Clinic (Direct GLP)
Graded #144

Higher grade

The verdict

Primary Clinic (Direct GLP) takes it — 68.7/100 to 61.9/100.

Primary Clinic (Direct GLP) grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valuePrimary Clinic (Direct GLP) +17
61
78
Dose & formulationKERNX Health +10
64
54
Clinical oversightPrimary Clinic (Direct GLP) +4
71
75
Labs & monitoringPrimary Clinic (Direct GLP) +24
52
76
FulfillmentPrimary Clinic (Direct GLP) +4
69
73
Contract termsKERNX Health +4
45
41
KERNX Health · left barPrimary Clinic (Direct GLP) · right bar

The numbers

MetricKERNX HealthPrimary Clinic (Direct GLP)
WeighScore61.9/10068.7/100
GradeCC
Scorecard rank#282#144
Semaglutide$129/mo (promotional rate, plus a separate fee, compounded)$65/mo (0.25 mg dose, promotional rate, compounded)
Tirzepatide$199/mo (promotional rate, plus a separate fee, compounded)$110/mo (2.5 mg dose, promotional rate, compounded)
CoverageCoverage not published10 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
KERNX Health

Graded #282 · C

Strengths

  • Publishes plan pricing openly, before any intake or account creation
  • Month-to-month with no long-term contract and no multi-month prepayment
  • Billing starts only after a licensed provider approves treatment
  • LegitScript certification verified against the issued seal, not just the badge

Where it loses points

  • Its own pricing page contradicts itself: it claims no separate consultation charges, then states a $25-$60 fee applies per visit
  • The consultation fee is charged whether or not a prescription is issued
  • Advertised $129 and $199 rates are time-limited founding rates; standard rates are $249 and $299
  • No compounding pharmacy is named anywhere on the site
  • Shipping claims conflict: a 48-hour figure on the homepage against 1-2 days to ship plus 2-3 days transit in the FAQ

Strengths

  • Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
  • GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
  • Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
  • Routine labs and thousands of medications included in membership — no surprise bills
  • Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide

Where it loses points

  • 10 states only (WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA) — limited vs 50-state platforms
  • Membership required to access wholesale pricing — $89/mo adds ~$1,068/yr in fixed cost
  • 503A pharmacy partners not named
  • LegitScript certification not mentioned on the site
  • Medical director and corporate legal entity not disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard